Screening immune adjuvants for an inactivated vaccine against Erysipelothrix rhusiopathiae

Li-Jun Guan; Shi-Xuan Pei; Ji-Jian Song; Peng-Fei Zhan; Yi-Nong Han; Yun Xue; Ke Ding; Zhan-Qin Zhao

doi:10.3389/fvets.2022.922867

Screening immune adjuvants for an inactivated vaccine against Erysipelothrix rhusiopathiae

Front Vet Sci. 2022 Jul 26:9:922867. doi: 10.3389/fvets.2022.922867. eCollection 2022.

Authors

Li-Jun Guan^{1

2}, Shi-Xuan Pei¹, Ji-Jian Song¹, Peng-Fei Zhan¹, Yi-Nong Han¹, Yun Xue¹, Ke Ding¹, Zhan-Qin Zhao¹

Affiliations

¹ Lab of Veterinary Microbiology, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.
² College of Veterinary Medicine, Jilin University, Changchun, China.

Abstract

In this study, we screened adjuvants for an inactivated vaccine against Erysipelothrix rhusiopathiae (E. rhusiopathiae). Inactivated cells of E. rhusiopathiae strain HG-1 were prepared as the antigen in five adjuvanted inactivated vaccines, including a mineral-oil-adjuvanted vaccine (Oli vaccine), aluminum-hydroxide-gel-adjuvanted vaccine (Alh vaccine), ISA201-biphasic-oil-emulsion-adjuvanted vaccine (ISA201 vaccine), GEL02-water-soluble-polymer-adjuvanted vaccine (GEL vaccine), and IMS1313-water-soluble-nanoparticle-adjuvanted vaccine (IMS1313 vaccine). The safety test results of subcutaneous inoculation in mice showed that Oli vaccine had the most severe side effects, with a combined score of 35, followed by the ISA201 vaccine (25 points), Alh vaccine (20 points), GEL vaccine (10 points), and IMS1313 vaccine (10 points). A dose of 1.5LD₅₀ of strain HG-1 was used to challenge the mice intraperitoneally, 14 days after their second immunization. The protective efficacy of Oli vaccine and Alh vaccine was 100% (8/8), whereas that of the other three adjuvanted vaccines was 88% (7/8). Challenge with 2.5LD₅₀ of strain HG-1 resulted in a 100% survival rate, demonstrating the 100% protective efficacy of the Oli vaccine, followed by the GEL vaccine (71%, 5/7), IMS1313 vaccine (57%, 4/7), ISA201 vaccine (43%, 3/7), and Alh vaccine (29%, 2/7). Challenge with 4LD₅₀ of strain HG-1 showed 100% (7/7) protective efficacy of the Oli vaccine and 71% (5/7) protective efficacy of the GEL vaccine, whereas the protective efficacy of other three adjuvanted vaccine was 14% (1/7). The Alh and GEL vaccines were selected for comparative tests in piglets, and both caused minor side effects. A second immunization with these two adjuvanted vaccines conferred 60 and 100% protective efficacy, respectively, after the piglets were challenged via an ear vein with 8LD₁₀₀ of strain HG-1. After challenge with 16LD₁₀₀ of strain HG-1, the Alh and GEL vaccines showed 40% and 100% protective efficacy, respectively. Our results suggested that GEL is the optimal adjuvant for an inactivated vaccine against E. rhusiopathiae.

Keywords: Erysipelothrix rhusiopathiae; adjuvant; protective efficacy; swine; vaccine.